VivoSim Labs, Inc. Increase (Decrease) in Contract with Customer, Liability
VivoSim Labs, Inc. (VIVS) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 12-month period ending 2021-03-31, per its 10-K filed 2021-06-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2021-06-15
- VivoSim Labs, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-03-31 was $0.00.
- VivoSim Labs, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2020-12-31 was $0.00.
- VivoSim Labs, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2020-09-30 was $0.00.
- VivoSim Labs, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. increase (decrease) in contract with customer, liability for fiscal 2021 was $0.00.
- VivoSim Labs, Inc. increase (decrease) in contract with customer, liability for fiscal 2020 was -$525.00K.
- VivoSim Labs, Inc. increase (decrease) in contract with customer, liability for fiscal 2019 was -$162.00K.
- VivoSim Labs, Inc. increase (decrease) in contract with customer, liability for fiscal 2018 was -$157.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 3 month as first filed | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $0.00 derived: sum of 2 quarters · filed 2021-06-15 | $0.00 derived: sum of 3 quarters · filed 2021-06-15 | $0.00 10-K · filed 2021-06-15 | |
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-08 | $0.00 derived: sum of 2 quarters · filed 2021-02-08 | $0.00 10-Q · filed 2021-02-08 | $0.00 derived: sum of 4 quarters · filed 2021-06-15 | |
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 3 quarters · filed 2021-06-15 | $0.00 derived: sum of 4 quarters · filed 2021-06-15 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 2 quarters · filed 2021-06-15 | $0.00 derived: sum of 3 quarters · filed 2021-06-15 | -$532.00K derived: sum of 4 quarters · filed 2021-06-15 | |
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $0.00 derived: sum of 2 quarters · filed 2021-06-15 | -$532.00K derived: sum of 3 quarters · filed 2021-06-15 | -$525.00K 10-K · filed 2021-06-15 | |
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-08 | -$532.00K derived: sum of 2 quarters · filed 2021-02-08 | -$525.00K 10-Q · filed 2021-02-08 | -$580.00K derived: sum of 4 quarters · filed 2021-02-08 | |
| 2019-09-30 | -$532.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05 | -$525.00K 10-Q · filed 2020-11-05 | -$580.00K derived: sum of 3 quarters · filed 2020-11-05 | -$619.00K derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $7.00K 10-Q · filed 2020-08-10 | -$48.00K derived: sum of 2 quarters · filed 2020-08-10 | -$87.00K derived: sum of 3 quarters · filed 2020-08-10 | -$113.00K derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | -$94.00K derived: sum of 2 quarters · filed 2020-05-28 | -$120.00K derived: sum of 3 quarters · filed 2020-05-28 | -$162.00K 10-K · filed 2020-05-28 | |
| 2018-12-31 | -$39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | -$65.00K derived: sum of 2 quarters · filed 2020-02-10 | -$107.00K 10-Q · filed 2020-02-10 | -$524.00K derived: sum of 4 quarters · filed 2020-02-10 | |
| 2018-09-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | -$68.00K 10-Q · filed 2019-11-07 | -$485.00K derived: sum of 3 quarters · filed 2019-11-07 | -$306.00K derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | -$42.00K 10-Q · filed 2019-08-08 | -$49.00K 10-Q · filed 2018-08-09 | -$459.00K derived: sum of 2 quarters · filed 2019-08-08 | -$280.00K derived: sum of 3 quarters · filed 2019-08-08 | -$461.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03 | -$238.00K derived: sum of 2 quarters · filed 2019-06-03 | -$419.00K derived: sum of 3 quarters · filed 2019-06-03 | -$157.00K 10-K · filed 2019-06-03 | |
| 2017-12-31 | $179.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07 | -$2.00K derived: sum of 2 quarters · filed 2019-02-07 | $260.00K 10-Q · filed 2019-02-07 | ||
| 2017-09-30 | -$181.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | $81.00K 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | $262.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |